JP2020533399A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020533399A5 JP2020533399A5 JP2020515882A JP2020515882A JP2020533399A5 JP 2020533399 A5 JP2020533399 A5 JP 2020533399A5 JP 2020515882 A JP2020515882 A JP 2020515882A JP 2020515882 A JP2020515882 A JP 2020515882A JP 2020533399 A5 JP2020533399 A5 JP 2020533399A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- disease
- cancer
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762558323P | 2017-09-13 | 2017-09-13 | |
| US62/558,323 | 2017-09-13 | ||
| PCT/US2018/050689 WO2019055528A1 (en) | 2017-09-13 | 2018-09-12 | NEW COMPOUND WITH SMALL MOLECULES |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020533399A JP2020533399A (ja) | 2020-11-19 |
| JP2020533399A5 true JP2020533399A5 (enExample) | 2021-10-21 |
| JP7170341B2 JP7170341B2 (ja) | 2022-11-14 |
Family
ID=65723058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020515882A Active JP7170341B2 (ja) | 2017-09-13 | 2018-09-12 | 新規低分子化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US11186550B2 (enExample) |
| EP (1) | EP3681874B1 (enExample) |
| JP (1) | JP7170341B2 (enExample) |
| KR (1) | KR102644045B1 (enExample) |
| CN (1) | CN111372921B (enExample) |
| AU (1) | AU2018331371C1 (enExample) |
| CA (1) | CA3075649A1 (enExample) |
| IL (1) | IL273242B2 (enExample) |
| WO (1) | WO2019055528A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102644045B1 (ko) | 2017-09-13 | 2024-03-05 | 셀리퓨트, 인코포레이티드 | 신규한 소분자 화합물 |
| JP7597722B2 (ja) * | 2019-02-27 | 2024-12-10 | セレピュート インコーポレイテッド | キナゾリノン化合物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060011785A (ko) * | 2002-06-27 | 2006-02-03 | 디 인다우먼트 포 리써치 인 휴먼 바이올로지, 인크. | Ａｌｄｈ 억제에 유용한 화합물 |
| US20050038051A1 (en) | 2003-06-09 | 2005-02-17 | Jodi Nunnari | Novel molecules for regulating cell death |
| CA2620248A1 (en) * | 2005-10-21 | 2007-04-26 | Merz Pharma Gmbh & Co. Kgaa | Chromenones and their use as modulators of metabotropic glutamate receptors |
| US8759097B2 (en) | 2011-04-19 | 2014-06-24 | University of Pittsburgh—of the Commonwealth System of Higher Eduction | Inhibition of dynamin related protein 1 to promote cell death |
| US9492450B2 (en) * | 2011-04-19 | 2016-11-15 | University of Pittsburgh—of the Commonwealth System of Higher Education | Inhibition of dynamin related protein 1 to promote cell death |
| JP2013142070A (ja) * | 2012-01-11 | 2013-07-22 | Nihon Univ | ミトコンドリア分裂阻害剤を用いたｔｒａｉｌ抵抗性の克服 |
| CN105008515A (zh) | 2012-12-28 | 2015-10-28 | 小利兰·斯坦福大学托管委员会 | 用于治疗线粒体疾病和用于使细胞分化成神经元的组合物和方法 |
| US9289448B2 (en) | 2013-03-15 | 2016-03-22 | Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for treating alzheimer's disease and other tauopathies |
| US9730935B2 (en) | 2013-12-13 | 2017-08-15 | The Board Of Trustees Of The Leland Stanford Junior University | Targeting a non-canonical notch signaling pathway for cancer treatment |
| GB201522232D0 (en) * | 2015-12-16 | 2016-01-27 | Liverpool School Tropical Medicine | Combination product |
| KR102644045B1 (ko) | 2017-09-13 | 2024-03-05 | 셀리퓨트, 인코포레이티드 | 신규한 소분자 화합물 |
-
2018
- 2018-09-12 KR KR1020207010525A patent/KR102644045B1/ko active Active
- 2018-09-12 CN CN201880070789.4A patent/CN111372921B/zh active Active
- 2018-09-12 EP EP18856020.5A patent/EP3681874B1/en active Active
- 2018-09-12 AU AU2018331371A patent/AU2018331371C1/en active Active
- 2018-09-12 CA CA3075649A patent/CA3075649A1/en active Pending
- 2018-09-12 US US16/647,383 patent/US11186550B2/en active Active
- 2018-09-12 JP JP2020515882A patent/JP7170341B2/ja active Active
- 2018-09-12 WO PCT/US2018/050689 patent/WO2019055528A1/en not_active Ceased
-
2020
- 2020-03-11 IL IL273242A patent/IL273242B2/en unknown
-
2021
- 2021-11-29 US US17/537,142 patent/US11912669B2/en active Active
-
2024
- 2024-02-26 US US18/587,753 patent/US12404251B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024071370A5 (enExample) | ||
| JP2023126440A5 (enExample) | ||
| JP2018518537A5 (enExample) | ||
| JP2015520151A5 (enExample) | ||
| JP2019524883A5 (enExample) | ||
| JP2010528026A5 (enExample) | ||
| JP2017538689A5 (enExample) | ||
| EA201690322A1 (ru) | Терапевтически активные соединения и способы их применения | |
| JP2019525899A5 (enExample) | ||
| JP2021530565A5 (enExample) | ||
| JP2015193630A5 (enExample) | ||
| RU2020121152A (ru) | Твердые формы ингибитора калликреина плазмы и их соли | |
| JP2013522326A5 (enExample) | ||
| JP2018534286A5 (enExample) | ||
| JP2014530818A5 (enExample) | ||
| JP2020533399A5 (enExample) | ||
| JP2019519533A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| JP2020523327A5 (enExample) | ||
| JP2020531463A5 (enExample) | ||
| JP2015516419A5 (enExample) | ||
| CN111788197A (zh) | 取代的二氨基杂环甲酰胺化合物及包含该化合物的组合物及其用途 | |
| JP2018145180A5 (enExample) | ||
| JPWO2020175629A5 (enExample) | ||
| JP2008536853A5 (enExample) |